Wichtige Dokumente

Gesamtdokumentation anzeigen

F8263

Eisen(II)-sulfat Heptahydrat

Name: Eisen(II)-sulfat Heptahydrat
Brand: SIGMA

suitable for plant cell culture, ≥99%

Sustainability features

Synonym(e):

Vitriolgrün

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern

Über diesen Artikel

Lineare Formel:

FeSO₄ · 7H₂O

CAS-Nummer:

7782-63-0

Molekulargewicht:

278.01

NACRES:

NA.71

PubChem Substance ID:

24894960

UNSPSC Code:

12352207

EC Number:

231-753-5

MDL number:

MFCD00149719

Assay:

≥99%

Technischer Dienst

Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.

Unterstützung erhalten

Eigenschaften

vapor pressure

14.6 mmHg ( 25 °C)

Quality Segment

200

assay

≥99%

shelf life

2 yr

greener alternative product characteristics

Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

sustainability

Greener Alternative Product, Sustainability features

technique(s)

cell culture | plant: suitable

density

1.898 g/mL at 25 °C (lit.)

greener alternative category

, Enabling

SMILES string

O.O.O.O.O.O.O.[Fe++].[O-]S([O-])(=O)=O

InChI

1S/Fe.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2

InChI key

SURQXAFEQWPFPV-UHFFFAOYSA-L

Beschreibung

General description

Iron(II) sulfate heptahydrate is used in cell culture applications generally bound to transferrin, citrate or other iron transport molecules.

We are committed to bringing you Greener Alternative Products, which belong to one of the four categories of greener alternatives. IRON(II) SULFATE HEPTAHYDRATE is essential for developing greener energy solutions, particularly in iron-based lithium-ion batteries. Its eco-friendly properties enhance energy storage efficiency, reduce reliance on harmful materials, and support the advancement of sustainable technologies. Click here for more information.

Application

Development of spherical iron(II) sulfate heptahydrate-containing solid particles with sustained drug release.: This study presents the development of spherical solid particles containing iron(II) sulfate heptahydrate aimed at sustained drug release applications. The focus was on optimizing the formulation for controlled release, which could be significant for future biochemistry and pharmacology research (Szabo-Revesz et al., 2007).